Common Contracts
6 similar Employment Agreement contracts by Foghorn Therapeutics Inc.
July 18, 2024Employment Agreement • November 4th, 2024 • Foghorn Therapeutics Inc. • Pharmaceutical preparations
This letter agreement (the “Agreement”) sets forth the terms and conditions of your employment with Foghorn Therapeutics Inc. (the “Company”). This Agreement will be effective as of July 18, 2024.
April 12, 2024Employment Agreement • April 16th, 2024 • Foghorn Therapeutics Inc. • Pharmaceutical preparations
This letter agreement (the “Agreement”) sets forth the terms and conditions of your employment with Foghorn Therapeutics Inc. (the “Company”). This Agreement will be effective as of April 16, 2024.
August 4, 2023Employment Agreement • November 2nd, 2023 • Foghorn Therapeutics Inc. • Pharmaceutical preparations
This letter agreement (the “Agreement”) sets forth the terms and conditions ofyour employment with Foghorn Therapeutics Inc. (the “Company”). This Agreement will be effective as of August 7, 2023.
October 14, 2020 Sam Agresta By Email Delivery Dear Sam:Employment Agreement • October 19th, 2020 • Foghorn Therapeutics Inc. • Pharmaceutical preparations
This letter agreement (the “Agreement”) amends and restates the offer letter dated July 14, 2019 (the “Offer Letter”) by and among you and Foghorn Therapeutics Inc. (the “Company”). This Agreement sets forth the terms and conditions of your continued employment with the Company. This Agreement will be effective as of the date on which the Company becomes subject to the reporting obligations of Section 12 of the Securities Exchange Act of 1934, as amended. Should this not occur for any reason, this Agreement shall be void and of no force or effect.
Execution VersionEmployment Agreement • October 19th, 2020 • Foghorn Therapeutics Inc. • Pharmaceutical preparations
This letter agreement (the “Agreement”) amends and restates the offer letter dated December 5, 2018 (the “Offer Letter”) by and among you and Foghorn Therapeutics Inc. (the “Company”). This Agreement sets forth the terms and conditions of your continued employment with the Company. This Agreement will be effective as of the date on which the Company becomes subject to the reporting obligations of Section 12 of the Securities Exchange Act of 1934, as amended. Should this not occur for any reason, this Agreement shall be void and of no force or effect.
October 14, 2020 Adrian Gottschalk By Email Delivery Dear Adrian:Employment Agreement • October 19th, 2020 • Foghorn Therapeutics Inc. • Pharmaceutical preparations
This letter agreement (the “Agreement”) amends and restates the offer letter dated April 20, 2017 (the “Offer Letter”) by and among you and Foghorn Therapeutics Inc. (the “Company”). This Agreement sets forth the terms and conditions of your continued employment with the Company. This Agreement will be effective as of the date on which the Company becomes subject to the reporting obligations of Section 12 of the Securities Exchange Act of 1934, as amended. Should this not occur for any reason, this Agreement shall be void and of no force or effect.
